Back to life: Can controversial stem cell treatment revive brain-dead patients?

brain dead

For any given medical problem, it seems, there’s a research team trying to use stem cells to find a solution…But in one study expected to launch later this year, scientists hope to use stem cells in a new, highly controversial way — to reverse death.

The idea of the trial, run by Philadelphia-based Bioquark, is to inject stem cells into the spinal cords of people who have been declared clinically brain-dead. The subjects will also receive an injected protein blend, electrical nerve stimulation, and laser therapy directed at the brain.

The ultimate goal: to grow new neurons and spur them to connect to each other, and thereby bring the brain back to life.


This isn’t the first start for the trial. The study launched in Rudrapur, India, in April 2016 — but it never enrolled any patients. Regulators shut the study down in November 2016 because…India’s Drug Controller General hadn’t cleared it.

Now, the company is in the final stages of finding a new location to host trials. The company will announce a trial in Latin America in coming months….

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Resurrected: A controversial trial to bring the dead back to life plans a restart

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend